相关实验视频

Updated: Jun 22, 2026

Rapid Isolation And Purification Of Mitochondria For Transplantation By Tissue Dissociation And Differential Filtration

Rapid Isolation And Purification Of Mitochondria For Transplantation By Tissue Dissociation And Differential Filtration

Published on: September 6, 2014

线粒体移植:一种用于肝脏缺血/再生输液损伤的新疗法

Avinash Naraiah Mukkala^1,2, Bruna Araujo David^3,4, Menachem Ailenberg¹

¹Keenan Research Centre for Biomedical Science, Department of Surgery, St. Michael's Hospital, Unity Health Toronto; Toronto, ON, Canada.

Annals of surgery

|February 6, 2025

概括

线粒体移植 (MTx) 通过使Kupffer细胞 (KCs) 能够通过免疫球蛋白超级家族 (CRIg) 的补充受体捕获线粒体,从而保护肝脏免受缺血/反 (I/R) 损伤. 这项研究阐明了一种用于保护肝脏的新型治疗机制.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
线粒体生物学线粒体生物学

背景情况:

肝脏缺血/反 (I/R) 损伤导致肝细胞损伤,原因是线粒体功能障碍.
线粒体移植 (MTx) 是I / R的潜在治疗方法,但其在肝损伤中的机制尚不清楚.

研究的目的:

为了研究MTx在小鼠肝脏模型中的肝脏保护作用,I/R.
阐明MTx介导保护的细胞和分子机制.

主要方法:

使用了肝脏I / R的体内小鼠模型.
在体内成像和淘汰/转基因小鼠模型中使用 (Clec4f/iDTR,CRIg缺乏).
评估肝损伤标志物 (ALT,AST,组织学) 和炎症性细胞因子 (IL-6,TNFα,IL-10).

主要成果:

MTx显著降低了肝损伤和炎症 (ALT,AST,IL-6,TNFα降低;IL-10增加).
MTx在局部和远程减少了中性粒细胞的透.
库弗弗细胞 (KC) 通过免疫球蛋白超级家族 (CRIg) 的补充受体捕获移植的线粒体,这对MTx疗效至关重要.

结论:

基因细胞对CRIg依赖的线粒体捕获是MTx介导的肝保护的关键机制.
这些发现提升了对MTx的理解,并表明了肝损伤临床应用的潜力.

关键词:

CRIggg 在CRIgg 中使用.库弗弗细胞是库弗弗细胞.这是一种炎症炎症炎症炎症.肝脏缺血/反损伤的情况线粒体中的线粒体.

更多相关视频

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

Model of Ischemia and Reperfusion Injury in Rabbits

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...